Background {#Sec1}
==========

The study of molecular-genetic mechanisms of hypertension is an important task for biology and medicine. Multifactorial etiology of hypertension complicates the solution of this problem, and despite of numerous studies, the basal molecular mechanisms of essential hypertension remain not fully elucidated. However, it has long been known that renal dysfunction underlies the development of all forms of hypertension in experimental animals and humans \[[@CR1]--[@CR4]\].

The ISIAH (Inherited Stress-Induced Arterial Hypertension) rat strain was developed to study the genetic background of the stress-sensitive form of arterial hypertension and its complications. Selection of the ISIAH rats from an outbred Wistar stock was performed for a systolic arterial blood pressure (BP) elevation induced by 0.5 h emotional stress, which was caused by keeping the rats restricted in a small wire mesh cage. The ISIAH rats acquire the elevated basal systolic arterial BP at the age of 6 weeks (175.0 ± 3.5 mmHg in males and 165.0 ± 3.0 mmHg in females) and systolic arterial BP in these rats dramatically increases under the restriction conditions \[[@CR5], [@CR6]\]. The development of the hypertensive state in ISIAH rats is also accompanied by a hypertrophy of the left ventricle, increase in the wall thickness of the small arteries, and changes in the electrocardiographic pattern \[[@CR6]\]. The studies on the kidney histology showed the alterations, which were indicative of an increase in filtration barrier functional load and of processes leading to the development of glomerular \[[@CR7]\] and medullary sclerosis in ISIAH rats \[[@CR8]\].

The unraveling of the genetic basis of the renal function in ISIAH rats may be useful for understanding the mechanisms underlying the stress-sensitive hypertension development and for identifying the molecular determinants, which may be potentially used as the therapeutic targets for pharmacological intervention.

Recently, using the next-generation RNA sequencing (RNA-Seq) approach, we analyzed the renal cortex transcriptome in ISIAH rats \[[@CR9]\]. The results of this study showed that the functioning of the renal cortex in ISIAH rats is based on the changes in transcriptional activity of multiple genes related to different biological processes and metabolic pathways. However, in a number of studies it was demonstrated that the initial changes leading to the pathology of renal function begin from medullary blood flow reduction, and these changes may exert significant effects on sodium and water homeostasis and on the long-term control of arterial BP \[[@CR2], [@CR10], [@CR11]\].

Thus, the goal of the current study was to uncover the genetic basis of the changes underlying the renal medulla function in the ISIAH rats and to reveal the features which possibly may be related to the alterations in medullary blood flow. To achieve this goal the RNA-Seq approach was used for transcriptome profiling of the renal medulla from hypertensive ISIAH and normotensive WAG rats. The differentially expressed genes (DEGs) related to stress-sensitive hypertension and possibly to the alterations in medullary blood flow as well as the metabolic pathways contributing to the inter-strain differences in renal medulla functions were detected. Several DEGs, which may modulate the renal medulla blood flow, were identified and their possible impact on the process was discussed.

Results {#Sec2}
=======

The expression of 13,646 genes was detected in the renal medulla of analyzed rats. The comparative analysis of their expression in the renal medulla of ISIAH and WAG rats revealed 960 DEGs (listed in the Additional file [1](#MOESM1){ref-type="media"}). The Additional file [2](#MOESM2){ref-type="media"} represents the heatmap for the DEGs. Approximately a half of these genes (524 genes, i.e., 54.7%) were down-regulated in the renal medulla of ISIAH rats. The expression of 11 genes was detected in renal medulla of only one rat strain (Additional file [3](#MOESM3){ref-type="media"}). One of these genes (*Retn,* resistin) is known as associated with hypertension. Its expression was detected in renal medulla of ISIAH rats but not in WAG. The list of the top 40 genes with the highest differences in their expression in renal medulla of ISIAH and WAG rats included two genes (*Acsm3,* acyl-CoA synthetase medium-chain family member 3; and *Ephx2,* epoxide hydrolase 2, cytoplasmic), which were annotated in Rat Genome Database (RGD) as genes related to hypertension (Table [1](#Tab1){ref-type="table"}).Table 1Top 40 genes with the greatest difference in expression between ISIAH and WAG renal medullaGene symbolNCBI gene IDGene definitionlog2 (fold_change) ISIAH/WAG*LOC102546948*102546948uncharacterized LOC102546948−5.73*Galnt13*311039UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)−5.56*Pdilt*293544protein disulfide isomerase-like, testis expressed−5.17*LOC501110*501110similar to Glutathione S-transferase A1 (GTH1) (HA subunit 1) (GST-epsilon) (GSTA1-1) (GST class-alpha)−4.59*Slc10a2*29500solute carrier family 10 (sodium/bile acid cotransporter), member 2−4.40*Pcdh9*306091protocadherin 9−4.23*LOC100909561*100909561nuclease-sensitive element-binding protein 1-like−3.74*Car5a*54233carbonic anhydrase 5a, mitochondrial−3.74*LOC100361907*100361907complement factor H-related protein B−3.73*Sphkap*316561SPHK1 interactor, AKAP domain containing−3.65*LOC102552001*102552001uncharacterized LOC102552001−3.62*LOC102550987*102550987uncharacterized LOC102550987−3.57*Kcnj5*29713potassium inwardly-rectifying channel, subfamily J, member 5−3.23*Upk2*689093uroplakin 23.12*LOC102555352*102555352uncharacterized LOC1025553523.13*LOC102551856*102551856uncharacterized LOC1025518563.21*Spta1*289257spectrin, alpha, erythrocytic 1 (elliptocytosis 2)3.28*LOC686967*686967similar to olfactory receptor 14423.34*Acsm3* ^a^24763acyl-CoA synthetase medium-chain family member 33.40*LOC100911960*100911960UDP-glucuronosyltransferase 1-9-like3.44*Thrsp*25357thyroid hormone responsive3.51*Sprr1a*499660small proline-rich protein 1A3.51*Hpgd*79242hydroxyprostaglandin dehydrogenase 15 (NAD)3.52*LOC102553290*102553290collagen alpha-1(III) chain-like3.62*Ly6al*362935lymphocyte antigen 6 complex, locus A-like3.65*Akr1b8*286921aldo-keto reductase family 1, member B83.70*Shisa3*498356shisa family member 33.83*Nefh*24587neurofilament, heavy polypeptide3.90*Tcerg1l*361669transcription elongation regulator 1-like4.09*Krt19*360626keratin 194.18*Ephx2* ^a^65030epoxide hydrolase 2, cytoplasmic4.52*Ubd*29168ubiquitin D4.61*Resp18*50561regulated endocrine-specific protein 184.65*Serpinb12*304692serpin peptidase inhibitor, clade B (ovalbumin), member 125.38*Car3*54232carbonic anhydrase 35.54*Fam111a*499322family with sequence similarity 111, member A5.86*LOC100362069*100362069ribosomal protein L28-like6.11*Gys2*25623glycogen synthase 26.38*Stk32c*365381serine/threonine kinase 32C6.41*RGD1565131*49814360S ribosomal protein L15-like8.94^a^Genes are annotated in Rat Genome Database (<http://rgd.mcw.edu/>) as associated with hypertension. ISIAH and WAG -- rat strains used in the study

The genes making the strongest contribution to the inter-strain differences were detected by the partial-least squares discriminant analysis (PLS-DA). The distances between ISIAH and WAG rats are shown in Fig. [1a](#Fig1){ref-type="fig"}, and the results of the correlation analysis between gene expression and PLS-DA Axis 1 are presented in Fig. [1b](#Fig1){ref-type="fig"}. The DEGs are shown in red in Fig. [1b](#Fig1){ref-type="fig"}. The DEGs in the most polar position contribute the most to the inter-strain variations. The correlation coefficients for *Acsm3* and *Ephx2* were 0.996 and 0.994, correspondingly. Hence, *Acsm3* and *Ephx2* may be considered as genes making the strongest contribution to the inter-strain differences. The differential expression of these and several other genes was validated by real-time PCR (Fig. [2](#Fig2){ref-type="fig"}). The correlation between the gene expression estimated by two methods (RNA-Seq and real-time PCR) was 0.99 (Fig. [3](#Fig3){ref-type="fig"}).Fig. 1**a** Axes maximizing the distances between ISIAH and WAG rats. **b** The distribution of expressed genes along the first axis. The data are based on the Pearson correlation coefficients between the first axis and the level of genes expression Fig. 2The relative mRNA abundance measured by qPCR. The normalized mRNA level in control samples of the WAG rats was assigned a value of 1. *Vertical bars* show the standard error of the mean, and significance of inter-strain difference is indicated by \**p \<* 0.05, \*\**p \<* 0.01, \*\*\**p \<* 0.001 Fig. 3Comparison of gene expression level measurements obtained by RNA-seq and qPCR

According to the RGD annotations, 58 DEGs found in the current study are associated with hypertension (Table [2](#Tab2){ref-type="table"}). Seven of them (*Agtr1a, Fn1, Gja1, Lama2, Mmp2, Mmp9, Nos3*) are known as being associated with renal hypertension. The functional annotation in Database for Annotation, Visualization and Integrated Discovery (DAVID) additionally revealed four DEGs (*Col1a2, Guca2b, P2rx4, Pcsk5*) related to BP regulation. The transcription of most of genes associated with hypertension (67.2%) was reduced in the renal medulla of ISIAH rats. About a half of the DEGs related to hypertension are also known as associated with diabetic nephropathy and insulin resistance, and two DEGs were found to be related to nephrosclerosis (Table [2](#Tab2){ref-type="table"}). Many of DEGs listed in the Table [2](#Tab2){ref-type="table"} are related to the diseases of immune system. The study revealed 76 DEGs referred to in RGD as associated with different renal diseases, such as renal insufficiency, nephrosclerosis, diabetic nephropathy, and renal fibrosis (Table [3](#Tab3){ref-type="table"}).Table 2Genes differentially expressed in ISIAH and WAG renal medulla and referred to in Databases as associated with hypertension and blood pressure regulationGene symbolNCBI gene IDGene namelog2 fold_change ISIAH/WAGRat Genome Database  *Acsm3* ^e^24763acyl-CoA synthetase medium-chain family member 33.40  *Adipoq* ^c,d,e^246253adiponectin, C1Q and collagen domain containing1.17  *Adra1b* ^c^24173adrenoceptor alpha 1B−1.31  *Adra2a*25083adrenoceptor alpha 2°−1.15  *Agtr1a* ^a,c,d,e^24180angiotensin II receptor, type 1°−0.47  *Alas1*65155aminolevulinate, delta-, synthase 10.74  *Angpt2* ^e^89805angiopoietin 2−0.79  *Aqp2* ^d^25386aquaporin 2 (collecting duct)−0.47  *Aqp4* ^e^25293aquaporin 4−0.59  *Clu* ^d,e^24854clusterin, transcript variant X1−0.80  *Cnr1* ^c^25248cannabinoid receptor 1 (brain)−0.58  *Comt*24267catechol-O-methyltransferase−0.67  *Corin*289596corin, serine peptidase−1.04  *Cst3* ^c,d,e^25307cystatin C−0.50  *Cyp1a1* ^e^24296cytochrome P450, family 1, subfamily a, polypeptide 1−0.51  *Cyp4f1*56266cytochrome P450, family 4, subfamily f, polypeptide 10.60  *Dio2* ^c^65162deiodinase, iodothyronine, type II−2.56  *Dusp1* ^e^114856dual specificity phosphatase 1−0.71  *Ebag9*299864estrogen receptor binding site associated, antigen, 90.49  *Emilin1*298845elastin microfibril interfacer 1−0.65  *Ephx1* ^e^25315epoxide hydrolase 1, microsomal (xenobiotic)0.70  *Ephx2* ^c,d^65030epoxide hydrolase 2, cytoplasmic4.52  *F2* ^d,\ e^29251coagulation factor II−0.93  *Fbn1* ^d^83727fibrillin 1, transcript variant X1−0.61  *Fn1* ^a,d,e^25661fibronectin 1−0.98  *Gja1* ^a,e^24392gap junction protein, alpha 10.99  *Gstm2*24424glutathione S-transferase mu 2−0.76  *Gstp1* ^e^24426glutathione S-transferase pi 10.53  *Hgf* ^c,d,e^24446hepatocyte growth factor−0.77  *Hsd17b4* ^e^79244hydroxysteroid (17-beta) dehydrogenase 40.52  *Igf1* ^d,e^24482insulin-like growth factor 1−0.75  *Itgav* ^c^296456integrin, alpha V−0.60  *Lama2* ^a^309368laminin, alpha 2−0.58  *Lox*24914lysyl oxidase−0.81  *Mif* ^c,e^81683macrophage migration inhibitory factor (glycosylation-inhibiting factor)0.55  *Mmp2* ^a,e^81686matrix metallopeptidase 2−0.54  *Mmp9* ^ad,e^81687matrix metallopeptidase 9−2.00  *Mthfr* ^b,d,e^362657methylenetetrahydrofolate reductase (NAD(P)H)0.49  *Nos3* ^a,c,d,e^24600nitric oxide synthase 3, endothelial cell−0.55  *Nox4* ^d^85431NADPH oxidase 40.50  *Pappa*313262pregnancy-associated plasma protein A−0.68  *Pecam1* ^d,e^29583platelet/endothelial cell adhesion molecule 1−0.45  *Ptgds* ^b,c,d^25526prostaglandin D2 synthase (brain)−0.78  *Ptk2b* ^c,e^50646protein tyrosine kinase 2 beta−0.79  *Retn* ^c,d,e^246250resistinexpression was detected only in ISIAH rats  *Rnpep*81761arginyl aminopeptidase (aminopeptidase B)−0.47  *RT1-Bb* ^e^309622RT1 class II, locus Bb−1.26  *Serpine2*29366serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2−0.55  *Slc26a4*29440solute carrier family 26 (anion exchanger), member 40.59  *Slc2a4* ^c^25139solute carrier family 2 (facilitated glucose transporter), member 4−0.76  *Slc5a2*64522solute carrier family 5 (sodium/glucose cotransporter), member 20.64  *Slc6a19*664630solute carrier family 6 (neutral amino acid transporter), member 190.48  *Slc8a1*29715solute carrier family 8 (sodium/calcium exchanger), member 10.53  *Slc9a3r2*116501solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2−0.49  *Sod3* ^c,d^25352superoxide dismutase 3, extracellular0.56  *Tacr3*24808tachykinin receptor 3−1.22  *Tf* ^c,d,e^24825transferrin−1.43  *Vcam1* ^c,d,e^25361vascular cell adhesion molecule 1−0.86DAVID  *Col1a2* ^e^84352collagen, type I, alpha 2−0.53  *Guca2b*64055guanylate cyclase activator 2B2.03  *P2rx4*29659purinergic receptor P2X, ligand-gated ion channel 4−1.41  *Pcsk5*116548proprotein convertase subtilisin/kexin type 50.73ISIAH and WAG -- rat strains used in the study. *DAVID* -- Database for Annotation, Visualization and Integrated Discovery (<http://david.abcc.ncifcrf.gov/>)Genes associated with: ^a^renal hypertension; ^b^nephrosclerosis; ^c^insulin resistance; ^d^diabetic nephropathy; ^e^immune system diseases Table 3Genes differentially expressed in ISIAH versus WAG renal medulla and annotated in Rat Genome Database as associated with kidney diseasesGene symbolNCBI gene IDGene namelog2 fold change ISIAH/WAG*Acsm3*24763acyl-CoA synthetase medium-chain family member 33.40*Adipoq* ^c,d^246253adiponectin, C1Q and collagen domain containing1.17*Agtr1a* ^a,c,d^24180angiotensin II receptor, type 1a−0.47*Ak4* ^c^29223adenylate kinase 40.63*Alpl*25586alkaline phosphatase, liver/bone/kidney0.53*Amacr*25284alpha-methylacyl-CoA racemase0.50*Angpt2* ^a^89805angiopoietin 2−0.79*Anxa2*56611annexin A2−0.45*Apoh* ^d^287774apolipoprotein H (beta-2-glycoprotein I)−1.52*Aqp2* ^d^25386aquaporin 2 (collecting duct)−0.47*Baat*29725bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)0.78*Car2*54231carbonic anhydrase 20.53*Cftr*24255cystic fibrosis transmembrane conductance regulator−1.22*Cldn19*298487claudin 19−0.53*Clu* ^a,c,d^24854clusterin−0.80*Col3a1* ^a,c^84032collagen, type III, alpha 1−0.64*Col4a5*363457collagen, type IV, alpha 5−0.45*Comt*24267catechol-O-methyltransferase−0.67*Csf1r* ^c,d^307403colony stimulating factor 1 receptor−0.73*Cst3* ^d^25307cystatin C−0.50*Cubn* ^d^80848cubilin (intrinsic factor-cobalamin receptor)0.68*Cyp1a1* ^c^24296cytochrome P450, family 1, subfamily a, polypeptide 1−0.51*Cyp4a3*298423cytochrome P450, family 4, subfamily a, polypeptide 30.52*Dusp1*114856dual specificity phosphatase 1−0.71*Ebag9*299864estrogen receptor binding site associated, antigen, 90.49*Ephx2* ^c,d^65030epoxide hydrolase 2, cytoplasmic4.52*F2* ^c,d^29251coagulation factor II−0.93*Fbn1* ^a,d^83727fibrillin 1−0.61*Fga* ^c^361969fibrinogen alpha chain0.85*Fhit*60398fragile histidine triad1.58*Fmod* ^d^64507fibromodulin−1.09*Fn1* ^a,c,d^25661fibronectin 1−0.98*Gatm* ^c^81660glycine amidinotransferase (L-arginine:glycine amidinotransferase)0.86*Gja1*24392gap junction protein, alpha 10.99*Gpc1*58920glypican 1−0.72*Gstp1* ^c^24426glutathione S-transferase pi 10.53*Gtpbp4* ^c^114300GTP binding protein 43.01*Hao1*311446hydroxyacid oxidase (glycolate oxidase) 1−1.60*Hgf* ^d^24446hepatocyte growth factor−0.77*Igf1* ^d^24482insulin-like growth factor 1−0.75*Igfbp1* ^d^25685insulin-like growth factor binding protein 11.26*Il4r*25084interleukin 4 receptor0.64*Lama2*309368laminin, alpha 2−0.58*Lgals1*56646lectin, galactoside-binding, soluble, 10.88*Lrp1* ^a^299858low density lipoprotein receptor-related protein 1−0.53*Lrp5*293649low density lipoprotein receptor-related protein 5−0.47*Ltbp1*59107latent transforming growth factor beta binding protein 1−0.57*Mif*81683macrophage migration inhibitory factor (glycosylation-inhibiting factor)0.55*Mme*24590membrane metallo-endopeptidase1.35*Mmp2* ^a,\ c^81686matrix metallopeptidase 2−0.54*Mmp9* ^a,\ d^81687matrix metallopeptidase 9−2.00*Mok*362787MOK protein kinase−0.93*Mthfr* ^b*,*\ c,\ d^362657methylenetetrahydrofolate reductase (NAD(P)H)0.49*Nos3* ^c,\ d^24600nitric oxide synthase 3, endothelial cell−0.55*Nox4* ^d^85431NADPH oxidase 40.50*Nphs2* ^a^170672nephrosis 2, idiopathic, steroid-resistant0.57*Pecam1* ^d^29583platelet/endothelial cell adhesion molecule 1−0.45*Pla2g4a*24653phospholipase A2, group IVA (cytosolic, calcium-dependent)−0.69*Ptgds* ^b,\ d^25526prostaglandin D2 synthase (brain)−0.78*Ptk2b*50646protein tyrosine kinase 2 beta−0.79*Rap1gap* ^a^313644Rap1 GTPase-activating protein−0.60*Retn* ^c,\ d^246250resistinexpression was detected only in ISIAH rats*RT1-Bb*309622RT1 class II, locus Bb−1.26*Serpinf1* ^d^287526serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1−2.10*Serping1*295703serpin peptidase inhibitor, clade G (C1 inhibitor), member 10.56*Sfrp1*84402secreted frizzled-related protein 1−0.61*Slc17a2*306950solute carrier family 17, member 20.59*Slc19a3* ^c^316559solute carrier family 19 (thiamine transporter), member 31.00*Slc5a2*64522solute carrier family 5 (sodium/glucose cotransporter), member 20.64*Slc6a19*664630solute carrier family 6 (neutral amino acid transporter), member 190.48*Slit2*360272slit homolog 2 (Drosophila)0.45*Sod3* ^d^25352superoxide dismutase 3, extracellular0.56*Tf* ^d^24825transferrin−1.43*Timp2* ^d^29543TIMP metallopeptidase inhibitor 2−0.52*Vcam1* ^c,d^25361vascular cell adhesion molecule 1−0.86*Vtn* ^d^29169vitronectin−1.18Genes associated with: ^a^renal fibrosis; ^b^nephrosclerosis; ^c^renal insufficiency, ^d^diabetic nephropathy; ISIAH and WAG -- rat strains used in the study

The differential transcription of 59 transcription factor genes was found in the renal medulla of ISIAH and WAG rats (Table [4](#Tab4){ref-type="table"}). No one of these genes is currently referred to in databases as associated with arterial hypertension or kidney diseases.Table 4Transcription factor genes differentially expressed in ISIAH and WAG renal medullaGene symbolNCBI gene IDGene namelog2 fold_change ISIAH/WAG*Alx1*25401ALX homeobox 1−1.13*Arntl*29657aryl hydrocarbon receptor nuclear translocator-like−1.01*Bcl6*303836B-cell CLL/lymphoma 6−2.02*Bcl6b*360551B-cell CLL/lymphoma 6, member B−0.80*Bhlhe22*365748basic helix-loop-helix family, member e22−1.08*Bnc2*298189basonuclin 20.61*Btbd11*314675BTB (POZ) domain containing 11−0.65*Ccrn4l*310395CCR4 carbon catabolite repression 4-like (S, cerevisiae)0.64*Cebpd*25695CCAAT/enhancer binding protein (C/EBP), delta−0.83*Dab2*79128disabled 2, mitogen-responsive phosphoprotein0.49*Dmrt2*309430doublesex and mab-3 related transcription factor 2−0.55*Esrrb*299210estrogen-related receptor beta−0.58*Etv5*303828ets variant 5−0.70*Fhl1*25177four and a half LIM domains 11.09*Gcfc2*312474GC-rich sequence DNA-binding factor 2−0.61*Gne*114711glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase−0.51*Grhl1*313993grainyhead-like 1 (Drosophila)1.91*Hand2*64637heart and neural crest derivatives expressed 2expression was detected only in ISIAH rats*Hes6*316626hes family bHLH transcription factor 6−0.72*Id3*25585inhibitor of DNA binding 3−0.50*Id4*291023inhibitor of DNA binding 40.47*Ilf2*310612interleukin enhancer binding factor 2−0.46*Irf7*293624interferon regulatory factor 70.59*Irf8*292060interferon regulatory factor 8−0.58*Khdrbs3*64015KH domain containing, RNA binding, signal transduction associated 3−1.23*Lmo2*362176LIM domain only 2−0.79*Map2*25595microtubule-associated protein 2−1.44*Mcm7*288532minichromosome maintenance complex component 70.61*Mef2c*499497myocyte enhancer factor 2C−0.59*Mybl1*297783myeloblastosis oncogene-like 1−0.56*Nfkbil1*361794nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 10.98*Notch3*56761notch 3−0.50*Npas2*316351neuronal PAS domain protein 2−0.90*Nr2f1*81808nuclear receptor subfamily 2, group F, member 1−1.31*Nrip3*361625nuclear receptor interacting protein 3−0.83*Osr1*298878odd-skipped related transciption factor 1−1.29*Osr2*315039odd-skipped related transciption factor 21.17*P8*113900nuclear proten 1−0.95*Patz1*305471POZ (BTB) and AT hook containing zinc finger 10.57*Paxbp1*681004PAX3 and PAX7 binding protein 1−0.53*Pou2af1*690528POU class 2 associating factor 11.19*Prdm6*307305PR domain containing 61.50*Prox1*305066prospero homeobox 1−1.06*Sim1*309888single-minded family bHLH transcription factor 1−0.50*Smarcd3*296732SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3−0.58*Spry4*291610sprouty homolog 4 (Drosophila)−0.61*Stat5a*24918signal transducer and activator of transcription 5A0.63*Tcerg1l*361669transcription elongation regulator 1-like4.09*Tcf21*252856transcription factor 21−0.48*Tcf4*84382transcription factor 4−0.66*Tle2*299636transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila)−0.61*Zbtb16*353227zinc finger and BTB domain containing 16−1.11*Zdhhc2*246326zinc finger, DHHC-type containing 20.75*Zfhx2*305888zinc finger homeobox 2−0.88*Zfp189*313219zinc finger protein 189−0.62*Zfp354a*24522zinc finger protein 354A0.58*Zfp449*684901zinc finger protein 449−0.71*Zfp710*293044zinc finger protein 710−0.76*Zfp958*100302405zinc finger protein 958−0.64ISIAH and WAG -- rat strains used in the study

Gene Ontology (GO) terms for biological processes defined as significantly enriched within the analysis in DAVID are represented in Additional file [4](#MOESM4){ref-type="media"}. GO terms which might be essential for stress-sensitive hypertension development in ISIAH rats are shown in bold in this file, and the details for DEGs from these groups are given in Additional file [5](#MOESM5){ref-type="media"}.

The most significantly enriched GO terms were those related to oxidation reduction, lipid metabolic process, response to external stimulus as well as regulation of response to external stimuli. The analysis showed that the differences in renal medulla function between ISIAH and WAG rats are under control of many genes participating in response to hormone stimulus including genes associated with response to steroid (glucocorticoid) hormone stimulus.

Multiple DEGs were related to transport, (including sodium ion transport, water transport, glucose transport, lipid transport) and regulation of transport. Many DEGs associated with transport are annotated also as responsible for homeostatic process, including ion homeostasis.

Several GO terms were related to BP control. These were the groups of DEGs associated with blood circulation, regulation of BP, and negative regulation of blood coagulation.

Two large groups of DEGs were associated with response to stress and regulation of response to stress. The specificity of the stress types was defined by GO terms related to responses to oxidative stress, to osmotic stress, and to salt stress.

The other processes which might be involved in hypertension development in ISIAH rats were: neurogenesis, regulation of action potential in neuron, angiogenesis, regulation of smooth muscle cell differentiation, cell adhesion and regulation of cell adhesion.

The functional annotation underlined the important role of the immune system process and its regulation. The analysis in the Kyoto Encyclopedia of Genes and Genomes Pathway Database (KEGG) performed within the DAVID highlighted sixteen pathways that were significantly (p \< 0.05) enriched (Additional file [6](#MOESM6){ref-type="media"}). Several of them were also related to immune system functioning. All of the pathways contained genes annotated in RGD as associated with hypertension or with kidney diseases.

Discussion {#Sec3}
==========

The transcriptome profiling of the renal medulla from ISIAH and WAG rats let to identify multiple DEGs and several metabolic pathways contributing to differences between the renal medulla functions in ISIAH rats with stress-sensitive hypertension and normotensive controls. The functional annotation of DEGs within the analysis in Databases demonstrated that many of them are associated with hypertension and regulation of BP. One of these, *Retn*, was expressed in renal medulla of hypertensive rats but not in controls. However, the low level of expression of this gene was reported in kidney from Fischer 344 male rats, too \[[@CR12]\]. So, the inter-strain differences in transcriptional activity of *Retn* shouldn't be essential for hypertension development in ISIAH rats.

In recent years, it has become clear that a key determinant of the set point of the renal pressure-natriuresis curve is the balance of reactive oxygen and nitrogen species within the renal medullary region \[[@CR11]\]. The experimentally induced elevations of either superoxide or hydrogen peroxide in the renal medulla result in reduction of medullary blood flow, enhanced sodium reabsorption, and hypertension \[[@CR13]\].

In the current study, the group of DEGs described by GO term 'oxidation reduction' was the most significantly enriched one (Additional file [5](#MOESM5){ref-type="media"}). This group contained several genes associated with hypertension and some of them (*Cyp1a1,* cytochrome P450, family 1, subfamily a, polypeptide 1*; Cyp4f1,* cytochrome P450, family 4, subfamily f, polypeptide 1; *Nos3,* nitric oxide synthase 3, endothelial cell; *Nox4,* NADPH oxidase 4, *Sod3,* superoxide dismutase 3, extracellular) are known as involved in modulation of vascular tone and renal tubular function.

*Cyp1a1* knockout mice are hypertensive. Cyp1a1 metabolizes omega-3 polyunsaturated fatty acids to vasodilators and the loss of these vasodilators may lead to increases in BP \[[@CR14]\]. CYP1A1 contributes to eNOS (same as *Nos3*) activation, nitric oxide (NO) bioavailability, and NO-dependent BP regulation \[[@CR15]\]. So, the decreased level of *Cyp1a1* transcription in ISIAH renal medulla suggests its contribution to hypertension development in ISIAH rats.

CYP4F1 was characterized as the most critical 4 F isoform involved in the production of 20-hydroxyeicosatetraenoic acid (20-HETE), a potent eicosanoid that modulates vascular tone and renal tubular function \[[@CR16]\]. 20-HETE has been shown to play a complex role in BP regulation. In the kidney tubules, 20-HETE inhibits sodium reabsorption and promotes natriuresis, thus, contributing to antihypertensive mechanisms. In contrast, in the microvasculature, 20-HETE plays a pressor role by sensitizing smooth muscle cells to constrictor stimuli and increasing vascular myogenic tone, and by acting on the endothelium to further promote endothelial dysfunction and endothelial activation. In addition, 20-HETE induces endothelial angiotensin-converting enzyme, thus, setting forth a potential feed forward prohypertensive mechanism by stimulating the renin-angiotensin-aldosterone system (RAAS) \[[@CR17]\].

Nox4 is a hydrogen peroxide-producing NADPH oxidase isoform highly expressed in the kidney. NAD(P)H oxidase was recognized as the major source of reactive oxygen species (ROS) contributing to salt-induced hypertension \[[@CR18]\]. Dahl salt-sensitive hypertensive rats with knockout of Nox4 exhibited a reduced renal injury and attenuated BP response to high salt \[[@CR19]\]. Thus, we may suggest that the increased transcription of *Nox4* in the renal medulla of ISIAH rats may contribute to increased rate of ROS production and hypertension development.

Superoxide dismutases (SODs) convert superoxide to hydrogen peroxide, which is then removed by glutathione peroxidase or catalase \[[@CR20]\]. The oxidative stress appears to be a common feature of hypertensive disorders from diverse origins \[[@CR21]\], and it has been long known that oxidative stress induces or enhances the activity of SODs \[[@CR22]\]. Thus, the enhanced expression of *Sod3* provides a rationale to suggest the presence of the oxidative stress in the renal medulla of ISIAH rats which may require the enhanced activity of SOD3 to prevent the formation of highly aggressive ROS.

*Nos3* is known as related to the diversity of biological processes. In the current research, *Nos3* was related to GO term groups such as regulation of BP, oxidation reduction, response to stress and to steroid hormone stimulus, regulation of calcium and sodium ion transport, and angiogenesis (Additional file [5](#MOESM5){ref-type="media"}). Endothelial nitric oxide synthase (eNOS; NOS3) is physiologically important for vascular homeostasis \[[@CR23]\]. It is expressed predominantly in the endothelium of blood vessels where it catalyzes the production of NO. NO regulates vascular tone and local blood flow, platelet aggregation and adhesion, and leukocyte-endothelial cell interactions. Abnormalities in NO production by the vascular endothelium result in endothelial dysfunction, which occurs in hypertension, diabetes, aging, and as a prelude to atherosclerosis \[[@CR24]\].

*Nos3* transcription was found to be reduced in the renal medulla of ISIAH rats. The reduced eNOS expression was earlier reported for different models of hypertension: spontaneously hypertensive rats (SHR) \[[@CR25]\], Dahl salt-sensitive rats \[[@CR26]\], two-kidney, one-clip hypertensive rats \[[@CR27]\]. The reduced level of eNOS and NO production in the renal medulla is associated with a reduction in medullary blood flow and have considerable importance in sodium and water homeostasis and the long-term control of arterial pressure \[[@CR27]--[@CR29]\]. Recently, the reduced renal blood flow measured by magnetic resonance angiography was reported in ISIAH rats as compared to normotensive Wistar rats \[[@CR30]\]. So, the reduced transcription of the *Nos3* in the renal medulla of ISIAH rats may be considered as a key feature possibly leading to the medullary blood flow reduction. This, and the decreased NO availability in serum of ISIAH rats and its negative correlation with the BP reported earlier \[[@CR31]\], might indicate the impact of this mechanism on stress-sensitive hypertension development.

One more gene which may participate in regulation of NO availability in the renal medulla of ISIAH rats is *Ephx2* encoding the soluble epoxide hydrolase (sEH). In the current study, *Ephx2* was one of the DEGs associated with hypertension and showing the highest differences in expression in ISIAH and WAG renal medulla. sEH metabolizes the epoxyeicosatrienoic acids (EETs) having antihypertensive properties. EETs also possess anti-inflammatory actions that could protect the kidney vasculature from injury during renal and cardiovascular diseases \[[@CR32]\]. It was shown that P450 eicosanoids are vasodilatory, largely through their ability to activate eNOS and NO release \[[@CR33]\]. sEH is a main effector of angiotensin II-induced hypertension \[[@CR34]\]. *Ephx2* was also recognized as a gatekeeper gene contributing to programmed hypertension \[[@CR35]\]. In the current study, the PLS regression method, which is commonly used for biomarker selection in metabolomic \[[@CR36]\] and gene expression \[[@CR37]\] studies, reckoned *Ephx2* as one of the genes making the most significant contribution to the inter-strain differences. All this and the increased transcription of *Ephx2* found earlier in hypothalamus \[[@CR38]\] and renal cortex \[[@CR9]\] of ISIAH rats prompt us to consider *Ephx2* as a key candidate for further studies of the mechanisms underlying the stress-sensitive hypertension in ISIAH rats. The sEH was already considered as a suitable target for pharmaceutical intervention in the hypertension treatment \[[@CR39]\].

The other groups of DEGs, being among the most significantly enriched and described by GO terms 'response to external stimulus', 'response to hormone (endogenous) stimulus', 'response to stress', and 'homeostatic process', provide the molecular basis for integrated responses to homeostasis disturbances in the renal medulla of the ISIAH rats (Additional file [5](#MOESM5){ref-type="media"}). Most DEGs associated with BP regulation (*Adipoq, Adra1b, Agtr1a, Aqp2, Ephx2, Guca2b, Mif, Nos3, P2rx4, Tacr3*) were related to these groups. As it may be seen from the following discussion, some of these genes may contribute to vascular tone and renal blood flow regulation.

Adiponectin (*Adipoq* gene) stimulates production of nitric oxide in vascular endothelial cells \[[@CR40]\] and possess anti-atherogenic properties \[[@CR41]\]. The increased expression of *Adipoq* in renal medulla of ISIAH rats may be protective against the reduction in medullary blood flow.

*Agtr1a* (angiotensin II receptor, type 1a) encodes the receptor for angiotensin II, which is the main effector of RAAS \[[@CR42]\]. AT1A receptors expressed on the renal vasculature and/or renal tubular epithelia play a critical role in sodium and volume homeostasis \[[@CR43]\]. AGTR1a is required for mineralocorticoid receptor stimulation to induce vascular remodeling, inflammation and endothelial dysfunction \[[@CR44]\]. It was shown that in the euvolemic state the mean arterial pressure was significantly lower in the AT1A receptor-deficient mice compared with wild-type controls \[[@CR45]\]. So, the reduced transcription of *Agtr1a* in ISIAH renal medulla may be considered as a compensatory mechanism against the complications mentioned above.

The alpha1B-adrenoceptors (*Adra1b*) are involved in blood vessel remodeling \[[@CR46]\] and mediate the vasoconstrictor actions of the renal sympathetic nerves in rats with renal failure \[[@CR47], [@CR48]\]. *Adra1b* is one of the sympathetic nervous system (SNS) components \[[@CR49]\]. It is known that increased renal SNS activity reduces urinary sodium and water excretion, renal blood flow and glomerular filtration rate \[[@CR49]\]. Thus, the reduced transcription of *Adra1b* in ISIAH renal medulla may be considered as a protective mechanism against the excessive effects of SNS activation reported earlier in ISIAH rats \[[@CR50]\].

One more DEG, which may cause the differences in SNS activity in ISIAH and WAG rats is *Comt* (catechol-O-methyltransferase), which encodes the enzyme involved in the degradation of catecholamines. The inhibition of COMT induces dopamine-dependent natriuresis \[[@CR51]\]. The *Comt*-gene-disrupted mice were resistant to salt-induced hypertension \[[@CR52]\]. So, the decreased expression of *Comt* in the renal medulla of ISIAH rats may lead to increase in renal dopaminergic effects and sodium excretion, and may be considered as an adaptive or protective mechanism for control of hypertension development in ISIAH rats. Earlier, the significantly decreased transcription of *Comt* was also detected in kidney of 6-month old ISIAH rats \[[@CR53]\].

MIF (Macrophage migration inhibitory factor) possesses the ability to directly regulate the immunosuppressive actions of glucocorticoids and thus plays a critical role in the host control of inflammation and immunity \[[@CR54]\]. MIF is a key factor in atherogenesis \[[@CR55], [@CR56]\]. The upregulation of the podocyte-expressed MIF induces an injury of podocytes and accelerates the progression of glomerulosclerosis \[[@CR57]\]. In ISIAH rats, the upregulation of *Mif* gene was found both in renal cortex \[[@CR9]\] and in renal medulla (the current study), and possibly may contribute to development of atherosclerosis as well as to glomerulo- and medullary sclerosis histologically determined earlier \[[@CR7], [@CR8]\].

The changes in expression of DEGs associated with renal hypertension (*Agtr1a, Fn1, Gja1, Lama2, Mmp2, Mmp9, Nos3*) may also be suggested to have a significant impact on disease development in ISIAH rats (Table [2](#Tab2){ref-type="table"}).

Fibronectin 1 is a glycoprotein involved in cell--matrix and cell--cell adhesion \[[@CR58]\]. Fibronectin 1 may be induced by different agents including angiotensin II \[[@CR59]\] and aldosterone \[[@CR44]\]. Both of these stimuli may lead to vascular remodeling and vascular inflammation \[[@CR44], [@CR60]\]. So, the reduction in *Fn1* expression may be directed against the excessive vascular complications development in ISIAH renal medulla. It is worth also to mention that almost all (33 gene out of 37) of the multiple DEGs related to GO terms 'cell adhesion' and 'cell--matrix adhesion' were downregulated in ISIAH renal medulla (Additional file [5](#MOESM5){ref-type="media"}), and it is of high probability that those changes, at least in a part, are directed towards the prevention of vascular complications.

The protein encoded by *Gja1* (or *Cx43*, connexin 43) is a component of gap junctions, which permit the passage of ions and chemical mediators from cell to cell \[[@CR61]\]. The expression of connexins in renal arterioles is believed to have a profound impact on conducted responses, regulation of arteriolar tonus and renal blood flow. Besides, the cell-to-cell communication mediated by Cx43 channels may contribute to regulating the elasticity of the vascular wall \[[@CR62]\]. However, no evidence for an increased abundance of Cx43 in renal arterioles of SHR when compared with normotensive counterparts was found \[[@CR63]\]. In the ISIAH renal medulla the increased transcriptional level of *Gja1* was detected. Earlier a differential regulation of aortic Cx43 in different models of hypertension was reported \[[@CR62]\], and this may also be true for kidney. This may be one of the features distinguishing the mechanism of hypertension development in ISIAH rats from that in SHR.

LAMA2 is an extracellular matrix protein \[[@CR64]\] involved in regulation of cell adhesion. Matrix metalloproteinases (MMP2 and MMP9) belong to a family of metalloendopeptidases that cleave the protein components of the extracellular matrix and thereby play a central role in tissue remodeling \[[@CR65]\]. MMP2 (*Mmp2*) and MMP9 (*Mmp9*) are involved in the vascular smooth muscle cell activation and neointimal formation that characterize arterial tissue remodeling after injury \[[@CR66]\]. The overexpression of MMP9 and MMP2 have been observed within plaques \[[@CR67]\]. The elevated urine values of MMP-9 was recognized as a marker of atherosclerotic disease \[[@CR68]\], and, alternatively, the loss of MMP9 reduces atherosclerotic burden \[[@CR69]\]. MMP-2 also contributes to the development of atherosclerosis \[[@CR70]\]. Taking that into consideration, the decrease in *Mmp2* and *Mmp9* expression may be considered as protective against vascular remodeling in ISIAH renal medulla.

So, in ISIAH renal medulla, several DEGs associated with renal hypertension are related to cell--matrix and cell--cell adhesion processes. It is known that in hypertension the increase in arterial stretch stimulates vessel thickening to normalize the tensile forces. This process requires modification of the extracellular matrix and of cell--matrix interactions \[[@CR71]\]. The results of the current study are in a good agreement with this conception and highlighted the major DEGs contributing to the modification of the extracellular matrix and of cell--matrix interactions in renal medulla of rats with stress-sensitive hypertension.

Multiple genes with the changed level of transcription related to ion transport and to regulation of ion transport were found in the renal medulla of ISIAH rats. Many of these genes should be essential for maintaining the sodium and water balance in hypertensive state. However, it is not possible to discuss the role of all the DEGs contributing to these processes within the current paper. We just would like to mention that all the processes including such a basic one as sodium and water balance may undergo the strain-specific regulation. This may be seen, for example, in the case of the *Aqp2* being regulated by vasopressin \[[@CR72]\] and playing a role in body water balance \[[@CR73]\]. Mice with reduced expression of *Aqp2* have severe polyuria and very low urine osmolality \[[@CR74]\]. *Aqp2* transcription was reduced in renal medulla of ISIAH rats. The reduced AQP2 in the renal medulla was reported earlier in the clipped kidney of rats with experimental two-kidney, one clip hypertension \[[@CR75]\] and in Milan hypertensive rats \[[@CR76]\]. However, the medullary expression of AQP2 protein was increased in DOCA-salt hypertensive rats \[[@CR77]\] and in SHR \[[@CR78]\]. The existence of the strain-specific differences in the molecular mechanisms of the hypertension development points out the importance of the search for the common features contributing to disease manifestation which may be potentially used as new pharmacological targets.

Conclusions {#Sec4}
===========

The current study helped to identify a number of DEGs specifying the function of renal medulla in ISIAH rats being a model of the stress-sensitive arterial hypertension. The genes already known as associated with hypertension development were mostly discussed. However, the other genes also may have indirect influence on disease development and maintenance. The discussion demonstrated that the changes in expression of many genes may be considered as protective or adaptive and directed toward the integration and coordination of the general homeostasis of the organism. Several DEGs, which may modulate the renal medulla blood flow were detected. The reduced transcription of the *Nos3* points to the possible reduction of the blood flow in the renal medulla of ISIAH rats.

The generated data may be useful for comparison with those from different models of hypertension and for identifying the common molecular determinants contributing to disease manifestation which may be potentially used as new pharmacological targets. Based on discussion, *Ephx2* seems to be a promising candidate for further studies of its potential as therapeutic target.

Methods {#Sec5}
=======

Animals {#Sec6}
-------

The hypertensive ISIAH/Icgn and normotensive WAG/GSto-Icgn rat strains were used in the current study. Rats were bred in the Center for Genetic Resources of Laboratory Animals at the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, (Novosibirsk, Russia, RFMEFI61914X0005 and RFMEFI62114X0010). All rats were kept in standard laboratory conditions and had free access to food and water. The 3-month old ISIAH, and WAG male rats were used in RNA-seq experiments. Each group of experimental animals contained 3 rats. Rats were individually caged one week before the measurement of the systolic arterial BP, which was measured indirectly by the tail-cuff method as it was described earlier \[[@CR9]\]. The mean systolic arterial BP was 171.7 ± 1.22 mmHg in the experimental group of ISIAH males and 116.33 ± 1.86 mmHg in WAG. Six days after BP measurement, rats were decapitated and their kidneys were rapidly removed and sectioned. The samples of renal medulla were stored in RNA Later (Qiagen, Chatsworth, CA) at −70 °C until use. The animal experiments were conducted with approval of the Institute's Animal Care and Use Committee.

RNA-seq analysis {#Sec7}
----------------

The samples of renal medulla were sent to JSC Genoanalytica (Moscow, Russia), where the technological part of the RNA-seq analysis was conducted as it was described earlier {9}. Dynabeads mRNA Purification Kit (Ambion, USA) was used for mRNA extraction and NEBNext mRNA Library Prep Reagent Set for Illumina (NEB, USA) was used for cDNA libraries construction. All kits were used according to the manufacturer's protocol. cDNA libraries were sequenced using a HiSeq1500 Sequencing System (Illumina Sequencing, San Diego, USA) in a single end mode with a read length of 50 bases. Three biological replicates were analyzed for each rat strain. The sequencing data were subjected to adapter trimming and low-quality sequence removal and mapped to the rat reference genome (RGSC Rnor_5.0, rn5) with the use of Tophat2 \[[@CR79]\]. Quality metrics of the mapped libraries (Additional file [7](#MOESM7){ref-type="media"}) were collected using the Picard 'CollectRnaSeqMetrics' tool (<http://broadinstitute.github.io/picard/>). The differential expression analysis was performed using the Cufflinks workflow \[[@CR80]\]. A gene was defined as being expressed if it matched the Cufflinks criteria on suitability for statistical testing (test status 'OK'). Genes with a Benjamini-Hochberg adjusted p-value (q-value) \<0.05 were considered to be differentially expressed. Heatmap of the genes differentially expressed (q value \< 0.01) in the renal medulla of the ISIAH and WAG rats was built using the core functions of R statistical language (<https://cran.r-project.org/>); a hierarchical 'complete linkage' clustering by Euclidean distance was used to construct the dendrograms. The raw RNA-Seq data are available at the NCBI Short Read Archive database under the Accession number: PRJNA299102.

Functional annotation {#Sec8}
---------------------

The DEGs were functionally annotated in DAVID (The Database for Annotation, Visualization and Integrated Discovery) (<http://david.abcc.ncifcrf.gov/>) \[[@CR81], [@CR82]\] with the use of *Rattus norvegicus* genome as the background list for the over-representation analysis. The significantly enriched biological processes (p \< 0.05) were identified using the Gene Ontology option. The most significant to the data set pathways were identified in Kyoto Encyclopedia of Genes and Genomes Pathway Database (KEGG, <http://www.genome.jp/kegg/>). The annotation of DEGs in the Rat Genome Database Disease Portals (RGD, <http://rgd.mcw.edu/wg/portals?100>) was used to detect the genes related to arterial hypertension and renal diseases. The DEGs encoding the transcription factors were detected using the atlas of combinatorial transcriptional regulation in mouse and man \[[@CR83]\], GenBank (<http://www.ncbi.nlm.nih.gov/gene/>), and Panther classification system (<http://www.pantherdb.org/>) \[[@CR84]\].

Quantitative real-time PCR (qPCR) {#Sec9}
---------------------------------

To estimate the relative amount of target mRNA, qPCR analysis was performed on the renal medulla samples from ISIAH (n = 5) and WAG (n = 5) male rats aged as 3-month old. TRI reagent (Molecular research center, USA) was used for the extraction of the total RNA, and DNase I (Promega, USA) treatment was performed to remove the residual genomic DNA. The kits were used according to the manufacturer's recommendations.

The protocol for the reverse transcription was the following: the reaction was carried out with 40 units of MoMLV (Vektor-Best, Russia) in 50 μl of reaction mixture, which contained reverse transcription (RT) buffer, 0.4 mM dNTPs, 0.25 nmol of random nonanucleotide primers (Biosan, Russia), and 3 μg of total RNA. The cDNA synthesis was performed at 37 °C (1 h), 42 °C (30 min), and 50 °C (10 min) with the following inactivation of the enzyme by heating at 75 °C for 5 min.

The reaction volume for qPCR was 20 μl. It contained a master mix with SYBR Green, 0.15 mM of each forward and reverse primers, 1 unit of HotStart Taq polymerase (Vektor-Best, Russia), and the cDNA template. The *Rpl30* (ribosomal protein L30) stably expressed in different tissues from ISIAH and WAG rats was used as a reference gene. The primers sequences and characteristics are given in Additional file [8](#MOESM8){ref-type="media"}.

qPCR was performed in an iCycler iQ4 Real-Time PCR Detection System (Bio-Rad Laboratories, USA) using the protocol described earlier \[[@CR9]\]. Relative transcript levels were determined by standard-curve quantitation method \[[@CR85]\]. The mixture of the aliquots from all synthesized cDNA samples was used as a standard cDNA for calibration curves plotting. The value obtained for the target gene was normalized against the value for reference gene and then the relative mRNA abundance was calculated as a ratio of the normalized mRNA level in the experimental ISIAH samples to the normalized mRNA level in the samples from WAG rats. A value of 1 was assigned to the normalized mRNA level obtained for the samples from control WAG rats.

Statistical methods {#Sec10}
-------------------

Mann-Whitney U-test (Statistica v.8.0, Statsoft, USA) was used for calculations of the statistical significance for qPCR data. Statistical significance was set at p \< 0.05. The data were expressed as M ± S.E.M. (means and their standard errors).

The acquired RNA-seq data (FPKM values) were log transformed, centered and normalized to run the partial-least squares discriminant analysis (PLS-DA). First, the scaling of the data sets was performed using principal coordinates method based on Euclidean metric distances. Then, the pattern of co-variation for linear combinations between two blocks of variables \[[@CR86]\] was explored to get the separation of groups in PLS-DA. PLS-DA and the following calculation of Pearson correlation coefficients were performed to find a set of variables (expressed genes) that maximize the covariance between gene expression in ISIAH and WAG rat strains and fixed dummy matrix representing group membership \[[@CR86]\] for WAG and ISIAH rats, correspondingly. As a result of these procedures the PLS-DA Axes maximizing the distances between hypertensive and normotensive rats were constructed, the correlation between gene expression and PLS-DA Axis 1 was calculated, and the genes contributing the most to differences between ISIAH and WAG transcriptomes were revealed.

Additional files {#Sec11}
================

Additional file 1:Genes differentially expressed in renal medulla of hypertensive ISIAH and normotensive control WAG rats. (XLS 197 kb) Additional file 2:Heatmap of the differentially expressed genes in the renal medulla of the ISIAH and WAG rats. (PDF 50 kb) Additional file 3:Genes with detected expression in renal medulla of only one rat strain. (DOC 51 kb) Additional file 4:Functional annotation of differentially expressed genes (DEGs) found in 3-month old ISIAH and WAG renal medulla. (XLS 95 kb) Additional file 5:Differentially expressed genes related to Gene Ontlogy (GO) terms for biological processes in the renal medulla of 3-month old ISIAH and WAG male rats. (XLS 160 kb) Additional file 6:Metabolic pathways enriched with genes differentially expressed in ISIAH and WAG renal medulla. (XLS 41 kb) Additional file 7:The summary statistics for the sequenced libraries from renal medulla of ISIAH and WAG rats. (XLS 17 kb) Additional file 8:Primers used in real-time PCR. (DOC 33 kb)
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